1 INTRODUCTION 29
1.1 OBJECTIVES OF THE STUDY 29
1.2 MARKET DEFINITION & SCOPE 29
1.2.1 MARKETS COVERED 30
1.2.2 YEARS CONSIDERED FOR THE STUDY 31
1.3 CURRENCY 31
1.4 STAKEHOLDERS 32
1.5 LIMITATIONS 32

2 RESEARCH METHODOLOGY 33
2.1 RESEARCH APPROACH 33
2.1.1 SECONDARY DATA 33
2.1.1.1 Key data from secondary sources 35
2.1.2 PRIMARY DATA 35
2.1.2.1 Key data from primary sources 36
2.1.2.2 Key industry insights 37
2.2 MARKET SIZE ESTIMATION 38
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 44
2.4 MARKET RANKING ANALYSIS 45
2.5 ASSUMPTIONS FOR THE STUDY 45

3 EXECUTIVE SUMMARY 47

4 PREMIUM INSIGHTS 54
4.1 INFUSION PUMPS MARKET OVERVIEW 54
4.2 APAC: INFUSION PUMP DEVICES MARKET, BY PRODUCT & COUNTRY (2019) 55
4.3 INFUSION PUMPS MARKET: REGIONAL GROWTH OPPORTUNITIES 56
4.4 INFUSION PUMPS MARKET: DEVELOPING VS. DEVELOPED COUNTRIES 57

5 MARKET OVERVIEW 58
5.1 INTRODUCTION 58
5.2 MARKET DYNAMICS 58
5.2.1 MARKET DRIVERS 59
5.2.1.1 Rising demand for ambulatory infusion pumps in home care settings 59
5.2.1.2 Increasing incidence of chronic diseases along with the rapid growth of the geriatric population 59
5.2.1.3 Growing number of surgical procedures performed 61
_
5.2.2 MARKET RESTRAINTS 62
5.2.2.1 Product recalls 62
5.2.2.2 Stringent regulatory requirements for new products 64
5.2.2.3 Increasing adoption of refurbished and rental infusion pumps 64
5.2.3 MARKET OPPORTUNITIES 65
5.2.3.1 Emerging markets 65
5.2.3.2 Growing adoption of specialty infusion systems 66
5.2.4 MARKET CHALLENGES 67
5.2.4.1 Increasing incidence of medication errors and lack of wireless connectivity in most hospitals 67

6 INDUSTRY INSIGHTS 68
6.1 INTRODUCTION 68
6.2 PORTER’S FIVE FORCES ANALYSIS 68
6.2.1 THREAT OF NEW ENTRANTS 69
6.2.2 THREAT OF SUBSTITUTES 70
6.2.3 BARGAINING POWER OF SUPPLIERS 70
6.2.4 BARGAINING POWER OF BUYERS 70
6.2.5 COMPETITIVE RIVALRY 70
6.3 INDUSTRY TRENDS 71
6.3.1 SMART PUMP-EMR INTEROPERABILITY 71
6.3.2 GROWING FOCUS ON THE DEVELOPMENT OF HYBRID CLOSED-LOOP SYSTEMS/ARTIFICIAL PANCREAS DEVICE SYSTEMS 72
6.3.3 GROWING FOCUS ON SPECIALTY PUMPS & ADDED ADVANCED FEATURES 73

7 REGULATORY ANALYSIS 75
7.1 INTRODUCTION 75
7.1.1 NORTH AMERICA 75
7.1.1.1 US 75
7.1.1.2 Canada 77
7.1.2 EUROPE 78
7.1.3 APAC 79
7.1.3.1 Japan 79
7.1.3.2 China 79
7.1.3.3 India 80
7.1.4 LATIN AMERICA 81
7.1.4.1 Brazil 81
7.1.4.2 Mexico 83
_

8 INFUSION PUMPS MARKET, BY PRODUCT 85
8.1 INTRODUCTION 86
8.2 ACCESSORIES & CONSUMABLES 87
8.2.1 DEDICATED ACCESSORIES & CONSUMABLES 90
8.2.1.1 Volumetric infusion pumps 92
8.2.1.1.1 Volumetric infusion pump dedicated accessories & consumables account for the largest market share 92
8.2.1.2 Insulin pumps 93
8.2.1.2.1 Rising demand for insulin pumps for home healthcare to support the growth of this market segment 93
8.2.1.3 Enteral infusion pumps 94
8.2.1.3.1 Preference for low-cost, non-dedicated accessories in low-income countries to hamper market growth during the forecast period 94
8.2.1.4 Syringe infusion pumps 95
8.2.1.4.1 Adoption of dedicated syringe pump accessories is high in developed countries 95
8.2.1.5 Ambulatory infusion pumps 96
8.2.1.5.1 Growth in the home healthcare market is driving the growth of ambulatory infusion pump accessories & consumables 96
8.2.1.6 PCA pumps 96
8.2.1.6.1 Increasing demand for pain management treatment is driving the adoption of PCA pump accessories & consumables 96
8.2.1.7 Implantable infusion pumps 97
8.2.1.7.1 Dedicated implantable infusion pump accessories are preferred because of their compatibility with the pumps 97
8.2.2 NON-DEDICATED ACCESSORIES & CONSUMABLES 98
8.2.2.1 Infusion catheters 100
8.2.2.1.1 Infusion catheters segment accounted for the largest share of the non-dedicated accessories & consumables market 100
8.2.2.2 IV/administration sets 101
8.2.2.2.1 IV/administration sets are the primary requirement for infusion pumps 101
8.2.2.3 Needleless connectors 103
8.2.2.3.1 Needleless connectors are used to reduce bloodstream infection risks while providing infusion to patients 103
8.2.2.4 Cannulas 105
8.2.2.4.1 In terms of volume, the cannulas segment accounted for a major share of the non-dedicated accessories & consumables segment 105
8.2.2.5 Tubing & extension sets 107
8.2.2.5.1 Tubing & extension sets are used to provide a constant connection between a patient’s body and the infusion pump 107
_
8.2.2.6 Valves 109
8.2.2.6.1 Valves are used to regulate the flow of infusion fluid 109
8.2.2.7 Other non-dedicated accessories & consumables 111
8.3 DEVICES 112
8.3.1 DEVICES MARKET, BY PRODUCT 113
8.3.1.1 Volumetric infusion pumps 115
8.3.1.1.1 Volumetric infusion pumps account for a major share of the infusion pump devices market 115
8.3.1.2 Insulin pumps 117
8.3.1.2.1 The market for insulin pumps is projected to grow at a significant CAGR during the forecast period 117
8.3.1.3 Ambulatory infusion pumps 120
8.3.1.3.1 Disposable infusion pumps 123
8.3.1.3.1.1 The market for disposable infusion pumps accounted for a major share of the ambulatory infusion pumps market in 2019 123
8.3.1.3.2 Chemotherapy infusion pumps 125
8.3.1.3.2.1 Chemotherapy infusion pumps are designed to provide continuous infusion to cancer patients at home 125
8.3.1.4 Syringe infusion pumps 126
8.3.1.4.1 Syringe infusion pumps are used for the delivery of a lower volume of fluids at a low flow rate 126
8.3.1.5 Enteral infusion pumps 129
8.3.1.5.1 Enteral infusion pumps are designed to deliver nutrients and medicines into the patient’s digestive tract 129
8.3.1.6 PCA pumps 132
8.3.1.6.1 Growth in the pain management market is supporting the growth of the PCA pumps segment 132
8.3.1.7 Implantable infusion pumps 135
8.3.1.7.1 Need for surgical intervention for the placement of pumps and the high cost of the procedure are hampering the adoption of implantable infusion pumps 135
8.3.2 DEVICES MARKET, BY TYPE 137
8.3.2.1 Traditional infusion pumps 138
8.3.2.1.1 Traditional infusion pumps accounted for the largest market share in 2019 138
8.3.2.2 Specialty infusion pumps 139
8.3.2.2.1 Technological advancements & rising adoption of
specialty infusion pumps in home care settings to drive market growth 139

9 INFUSION PUMPS MARKET, BY APPLICATION 141
9.1 INTRODUCTION 142
9.2 CHEMOTHERAPY/ONCOLOGY 143
9.2.1 CHEMOTHERAPY/ONCOLOGY IS THE LARGEST APPLICATION
SEGMENT OF THE INFUSION PUMPS MARKET 143
9.3 DIABETES 145
9.3.1 DIABETES SEGMENT TO REGISTER THE HIGHEST GROWTH DURING
THE FORECAST PERIOD 145
9.4 GASTROENTEROLOGY 147
9.4.1 INCREASING INCIDENCE OF GASTROINTESTINAL DISEASES TO DRIVE MARKET GROWTH 147
9.5 ANALGESIA/PAIN MANAGEMENT 149
9.5.1 RISING NUMBER OF SURGICAL PROCEDURES TO PROPEL MARKET GROWTH 149
9.6 PEDIATRICS/NEONATOLOGY 151
9.6.1 INCREASING INCIDENCE OF DIABETES IN PEDIATRIC PATIENTS IS DRIVING THE ADOPTION OF INFUSION PUMPS 151
9.7 HEMATOLOGY 153
9.7.1 INCREASING PREVALENCE OF BLOOD DISORDERS TO SUPPORT THE GROWTH OF THIS SEGMENT 153
9.8 OTHER APPLICATIONS 155
10 INFUSION PUMPS MARKET, BY END USER 157
10.1 INTRODUCTION 158
10.2 HOSPITALS 159
10.2.1 HOSPITALS ARE THE LARGEST END USERS OF INFUSION PUMPS 159
10.3 HOME CARE SETTINGS 161
10.3.1 HOME CARE SETTINGS TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 161
10.4 AMBULATORY CARE SETTINGS 162
10.4.1 GROWING VOLUME OF SURGICAL PROCEDURES PERFORMED IN ASCS TO SUPPORT MARKET GROWTH 162
10.5 ACADEMIC & RESEARCH INSTITUTES 164
10.5.1 INCREASING MEDICAL RESEARCH ACTIVITIES TO SUPPORT THE GROWTH OF THIS END-USER SEGMENT 164
11 INFUSION PUMPS MARKET, BY REGION 166
11.1 INTRODUCTION 167
11.2 NORTH AMERICA 168
11.2.1 US 173
11.2.1.1 The US is the largest market for infusion pumps 173
11.2.2 CANADA 178
11.2.2.1 Increasing incidence of chronic diseases to support the adoption of infusion pumps in Canada 178
11.3 EUROPE 183
11.3.1 GERMANY 188
11.3.1.1 Germany holds the largest share of the European
infusion pumps market 188
11.3.2 FRANCE 193
11.3.2.1 Well-established healthcare system to support market
growth in France 193
11.3.3 UK 198
11.3.3.1 High burden of diabetes in the country to propel the growth of the infusion pumps market 198
11.3.4 ITALY 203
11.3.4.1 Growing demand for cost-effective home care services to support market growth 203
11.3.5 SPAIN 208
11.3.5.1 Rising prevalence of cancer to support the market for infusion pumps in Spain 208
11.3.6 REST OF EUROPE 213
11.4 ASIA PACIFIC 217
11.4.1 CHINA 222
11.4.1.1 China is the fastest-growing market for infusion pumps in the APAC 222
11.4.2 JAPAN 227
11.4.2.1 Large geriatric population in the country is driving the demand for infusion pumps 227
11.4.3 INDIA 232
11.4.3.1 High prevalence of lifestyle diseases in the country to drive the market for infusion pumps 232
11.4.4 REST OF APAC 237
11.5 LATIN AMERICA 241
11.5.1 BRAZIL 245
11.5.1.1 Brazil dominates the Latin American infusion pumps market 245
11.5.2 MEXICO 249
11.5.2.1 Rising prevalence of chronic diseases to drive market growth 249
11.5.3 REST OF LATIN AMERICA 254
11.6 MIDDLE EAST & AFRICA 258
11.6.1 IMPROVING HEALTHCARE INFRASTRUCTURE TO SUPPORT MARKET GROWTH 258

12 COMPETITIVE LANDSCAPE 263
12.1 OVERVIEW 263
12.2 PRODUCT BENCHMARKING 265
12.3 GEOGRAPHIC REACH OF THE TOP MARKET PLAYERS (2019) 266
12.4 R&D EXPENDITURE: KEY PLAYERS IN THE MARKET 267
12.5 MARKET SHARE ANALYSIS 268
12.5.1 VOLUMETRIC INFUSION PUMPS MARKET 269
12.5.2 SYRINGE INFUSION PUMPS MARKET 270
12.5.3 INSULIN PUMPS MARKET 270
12.5.4 ENTERAL INFUSION PUMPS MARKET 271
12.5.5 US: INFUSION PUMPS MARKET SHARE ANALYSIS 271
12.5.6 EUROPE: INFUSION PUMPS MARKET SHARE ANALYSIS 272
12.5.7 US: INSULIN PUMPS MARKET SHARE ANALYSIS 272
_
12.6 COMPETITIVE SITUATION AND TRENDS 273
12.6.1 PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS 273
12.6.2 PRODUCT APPROVALS, LAUNCHES, AND UPGRADES 274
12.6.3 EXPANSIONS 275
12.6.4 ACQUISITIONS 276
12.6.5 OTHER DEVELOPMENTS 276
12.7 COMPETITIVE LEADERSHIP MAPPING 277
12.7.1 VISIONARY LEADERS 277
12.7.2 INNOVATORS 277
12.7.3 DYNAMIC DIFFERENTIATORS 277
12.7.4 EMERGING COMPANIES 278

13 COMPANY PROFILES 279
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, Strategic Overview and Competitive Analysis)*
13.1 BECTON, DICKINSON AND COMPANY 279
13.2 B. BRAUN MELSUNGEN AG 284
13.3 BAXTER INTERNATIONAL INC. 293
13.4 FRESENIUS KABI 297
13.5 ICU MEDICAL, INC. 302
13.6 SMITHS MEDICAL (A DIVISION OF SMITHS GROUP PLC) 307
13.7 MEDTRONIC PLC 311
13.8 MOOG INC. 316
13.9 TERUMO CORPORATION 318
13.10 AVANOS MEDICAL, INC. 321
13.11 NIPRO CORPORATION 323
13.12 INSULET CORPORATION 325
13.13 TANDEM DIABETES CARE, INC. 327
13.14 JMS CO., LTD. 330
13.15 ROCHE DIAGNOSTICS (A DIVISION OF F. HOFFMANN-LA ROCHE LTD.) 332
13.16 ZYNO MEDICAL 334
13.17 TELEFLEX, INC. 335
13.18 MINDRAY MEDICAL INTERNATIONAL LIMITED 337
13.19 MICREL MEDICAL DEVICES S.A. 338
13.20 YPSOMED HOLDING AG 339
* Business Overview, Products Offered, Recent Developments, SWOT Analysis, Strategic Overview and Competitive Analysis might not be captured in case of unlisted companies.
_

14 APPENDIX 341
14.1 INSIGHTS OF INDUSTRY EXPERTS 341
14.2 DISCUSSION GUIDE 342
14.4 AVAILABLE CUSTOMIZATIONS 349
14.5 RELATED REPORTS 349
14.6 AUTHOR DETAILS 350